Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
4BB

4basebio PLC

4BBLSEUnited KingdomHealthcareBiotechnologyAIM

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a…more

P/B64.15xROIC-147.6%
£81.45M
Market Cap
EV: £90.64M
MOM1
QUAL3
VAL0
RSK8
4BB
£81.45M
Market Cap · EV £90.64M

4basebio PLC

MOM1
QUAL3
VAL0
RSK8

4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a…more

Latest RNS from 4basebio PLC

All 4BB news → · RNS daily feed

Analyst consensus: Buy

As of 10 Nov 2026, 3 analysts rate 4basebio PLC a Buy, with 100% buy ratings and a mean price target of 1,130p (range 940p–1,450p), +126% vs the current price.

Strong buy: 1Buy: 2Hold: 0Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies